1. Home
  2. OSS vs CCCC Comparison

OSS vs CCCC Comparison

Compare OSS & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Stop Systems Inc.

OSS

One Stop Systems Inc.

HOLD

Current Price

$8.39

Market Cap

197.3M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.11

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
CCCC
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.3M
185.1M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
OSS
CCCC
Price
$8.39
$3.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$8.50
$12.20
AVG Volume (30 Days)
1.5M
2.0M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
$37,027,382.00
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
34.46
1.02
52 Week Low
$1.85
$1.09
52 Week High
$12.75
$3.64

Technical Indicators

Market Signals
Indicator
OSS
CCCC
Relative Strength Index (RSI) 45.80 72.10
Support Level $7.96 $1.96
Resistance Level $10.74 N/A
Average True Range (ATR) 0.82 0.27
MACD -0.12 0.12
Stochastic Oscillator 20.18 92.71

Price Performance

Historical Comparison
OSS
CCCC

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: